AeroSafe Global announced the launch of its Patient and Provider Services which comprise Control Tower and Personalized Engagement, enable proactive monitoring of the delivery process with the personalized patient and provider engagement to minimize risk and improve the customer experience.
Control Tower enables manufacturers and specialty pharma to validate safe delivery by monitoring, measuring, and modeling transit data. Late deliveries can result in customer complaints, lost products, and regulatory challenges, making on-time delivery of temperature-sensitive products critical to effective use. With AeroSafe's integrated cold chain services, customers can monitor shipments to validate successful delivery, measure and verify the actual exposure of products during shipments, and model both past and future performance with data for specific parcel lanes.
Once therapeutics have been delivered, AeroSafe's Personalized Engagement service offers opportunities to extend information, resources, branding, and surveys to providers and patients. This service helps build meaningful connections with insights and communications, safeguards therapeutics with delivery and traceability confirmation, and simplifies the medication process with tailored messaging to provide clarity.
"Our recently launched 'Patient and Provider Services' offer our customers visibility and assurance of safe delivery, and enable them to engage with patients in new ways," said Jay McHarg, CEO of AeroSafe Global. "Through timely, personalized information, education, and support, we strive to enhance the patient experience and ultimately improve outcomes."
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!